Shield Therapeutics plc (AIM: STX)
London
· Delayed Price · Currency is GBP · Price in GBX3.300
+0.625 (23.36%)
Nov 21, 2024, 11:51 AM GMT+1
Shield Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -36.17 | -33.29 | -49.79 | -19.68 | -2.63 | -8.8 | Upgrade
|
| Depreciation & Amortization | 0.06 | 0.37 | 2.12 | 1.62 | 2.18 | 2.29 | Upgrade
|
| Other Amortization | 1.09 | 0.71 | 0.74 | 0.59 | 0.53 | 0.33 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 18.11 | - | - | - | Upgrade
|
| Stock-Based Compensation | 1.28 | 0.88 | 0.91 | 0.99 | 0.77 | 0.46 | Upgrade
|
| Other Operating Activities | 2.79 | 1.25 | 1.4 | 0.01 | 0.38 | 1.1 | Upgrade
|
| Change in Accounts Receivable | -5.3 | -7.01 | -2.79 | -2.88 | -0.26 | 0.68 | Upgrade
|
| Change in Inventory | -1.34 | -1.45 | 0.22 | -0.26 | -0.43 | -0.84 | Upgrade
|
| Change in Accounts Payable | 11.91 | 1.91 | 7.27 | 1.99 | -2.08 | 1 | Upgrade
|
| Change in Other Net Operating Assets | 4.88 | -0.48 | -0.78 | -0.64 | 0.15 | -0.29 | Upgrade
|
| Operating Cash Flow | -20.8 | -37.13 | -22.59 | -18.26 | -1.4 | -4.07 | Upgrade
|
| Capital Expenditures | -0.1 | -0.24 | -0.06 | -0.37 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -2.22 | -2.71 | -2.22 | -1.69 | -0.02 | -1.38 | Upgrade
|
| Other Investing Activities | 0.4 | 0.52 | 0.04 | 0.01 | 0 | 0.02 | Upgrade
|
| Investing Cash Flow | -1.92 | -2.43 | -2.25 | -2.05 | -0.02 | -1.37 | Upgrade
|
| Long-Term Debt Issued | - | 29.45 | 9.08 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -5.99 | -0.15 | -0.08 | -0.05 | -0.18 | Upgrade
|
| Net Debt Issued (Repaid) | 13.38 | 23.45 | 8.93 | -0.08 | -0.05 | -0.18 | Upgrade
|
| Issuance of Common Stock | 6.65 | 26.82 | 0.11 | 27.71 | 0.01 | 0.03 | Upgrade
|
| Other Financing Activities | -2.4 | -0.61 | -0.5 | 0.08 | -0.01 | -0.05 | Upgrade
|
| Financing Cash Flow | 17.63 | 49.66 | 8.53 | 27.71 | -0.05 | -0.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.41 | 0.45 | -1.13 | 1.78 | 0.27 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 4.5 | - | - | - | Upgrade
|
| Net Cash Flow | -5.5 | 10.55 | -12.94 | 9.18 | -1.2 | -5.64 | Upgrade
|
| Free Cash Flow | -20.89 | -37.37 | -22.66 | -18.63 | -1.4 | -4.07 | Upgrade
|
| Free Cash Flow Margin | -97.28% | -285.56% | -411.98% | -1226.73% | -13.48% | -565.51% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.05 | -0.10 | -0.09 | -0.01 | -0.03 | Upgrade
|
| Cash Interest Paid | 2.4 | 0.61 | 0.4 | 0.05 | 0.01 | 0.05 | Upgrade
|
| Cash Income Tax Paid | - | 0.72 | -0.71 | -0.59 | 0.09 | -1.31 | Upgrade
|
| Levered Free Cash Flow | -12.1 | -28.96 | -12.7 | -13.06 | 0.16 | -2.37 | Upgrade
|
| Unlevered Free Cash Flow | -10.81 | -28.33 | -12.45 | -13.06 | 0.16 | -2.36 | Upgrade
|
| Change in Net Working Capital | -10.23 | 7.75 | -5.85 | 1.51 | 1.97 | -1.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.